Urbana, IL, United States of America

Harry H S Fong

This inventor holds 1 USPTO granted patent. Top assignees: Hong Kong Baptist University, University of Illinois. Active years: 2017.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Harry H S Fong. Retrieved from https://idiyas.com/inventor/harry-h-s-fong

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2017

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Contributions of Harry H S Fong

Introduction

Harry H S Fong is a notable inventor based in Urbana, IL (US). He has made significant contributions to the field of cancer treatment through his innovative research and inventions. His work focuses on developing compounds that can effectively inhibit tumor growth, particularly in colon cancer.

Latest Patents

Fong holds a patent for "Anticancer maytansinoids with two fused macrocyclic rings." This invention provides maytansinoids that exhibit improved tumor inhibition activity. The method of treatment he developed utilizes maytansinoid compounds with two fused macrocyclic rings, showcasing his commitment to advancing cancer therapies. He has 1 patent to his name.

Career Highlights

Throughout his career, Fong has worked with prestigious institutions such as Hong Kong Baptist University and the University of Illinois. His research has contributed to the understanding and treatment of cancer, making a lasting impact in the medical field.

Collaborations

Fong has collaborated with esteemed colleagues, including Hongjie Zhang and Djaja D Soejarto. These partnerships have further enriched his research and innovation efforts.

Conclusion

Harry H S Fong's contributions to cancer treatment through his innovative inventions highlight the importance of research in developing effective therapies. His work continues to inspire advancements in the medical field.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…